CN106588701A - Amino acid derivative and preparation method and application thereof - Google Patents
Amino acid derivative and preparation method and application thereof Download PDFInfo
- Publication number
- CN106588701A CN106588701A CN201611096104.2A CN201611096104A CN106588701A CN 106588701 A CN106588701 A CN 106588701A CN 201611096104 A CN201611096104 A CN 201611096104A CN 106588701 A CN106588701 A CN 106588701A
- Authority
- CN
- China
- Prior art keywords
- fatty
- acid
- amino acid
- salt
- acylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003862 amino acid derivatives Chemical class 0.000 title description 2
- 238000002360 preparation method Methods 0.000 title description 2
- 150000003839 salts Chemical class 0.000 claims abstract description 41
- 244000005700 microbiome Species 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 230000002147 killing effect Effects 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 66
- 235000002639 sodium chloride Nutrition 0.000 claims description 45
- 239000002253 acid Substances 0.000 claims description 41
- 150000002148 esters Chemical class 0.000 claims description 23
- 229940024606 amino acid Drugs 0.000 claims description 19
- 235000001014 amino acid Nutrition 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 claims description 10
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 10
- 230000008014 freezing Effects 0.000 claims description 10
- 238000007710 freezing Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000001924 fatty-acyl group Chemical group 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 6
- 235000014304 histidine Nutrition 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical class NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960003121 arginine Drugs 0.000 claims description 2
- 235000009697 arginine Nutrition 0.000 claims description 2
- 150000001483 arginine derivatives Chemical class 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 235000009582 asparagine Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 235000004554 glutamine Nutrition 0.000 claims description 2
- 150000002410 histidine derivatives Chemical class 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 235000014705 isoleucine Nutrition 0.000 claims description 2
- 150000002668 lysine derivatives Chemical class 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 230000001629 suppression Effects 0.000 claims 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 1
- 241000432824 Asparagus densiflorus Species 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 238000005292 vacuum distillation Methods 0.000 claims 1
- -1 fatty acyl amino acid esters Chemical class 0.000 abstract description 29
- 239000007788 liquid Substances 0.000 abstract description 13
- 230000002829 reductive effect Effects 0.000 abstract description 13
- 239000003755 preservative agent Substances 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000000593 degrading effect Effects 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 description 22
- 238000012360 testing method Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- 239000002537 cosmetic Substances 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 230000002421 anti-septic effect Effects 0.000 description 6
- XJTMYVOVQZMMKX-KRWDZBQOSA-N ethyl (2s)-5-(diaminomethylideneamino)-2-(dodecanoylamino)pentanoate Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(=O)OCC)CCCN=C(N)N XJTMYVOVQZMMKX-KRWDZBQOSA-N 0.000 description 6
- XTJKNGLLPGBHHO-HNNXBMFYSA-N (2s)-5-(diaminomethylideneamino)-2-(dodecanoylamino)pentanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCCN=C(N)N XTJKNGLLPGBHHO-HNNXBMFYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 239000004398 Ethyl lauroyl arginate Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 235000019455 ethyl lauroyl arginate Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- OLDGKSQBWGEFNM-FQEVSTJZSA-N (2s)-6-amino-2-(hexadecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCCCN OLDGKSQBWGEFNM-FQEVSTJZSA-N 0.000 description 2
- XOAIXMQPJQVGRV-UHFFFAOYSA-N 1-hexadecanoylpyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N1CCCC1C(O)=O XOAIXMQPJQVGRV-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OLDGKSQBWGEFNM-UHFFFAOYSA-N Nalpha -palmitoyl-lysine Natural products CCCCCCCCCCCCCCCC(=O)NC(C(O)=O)CCCCN OLDGKSQBWGEFNM-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- VGMIHYGISGNHKU-UHFFFAOYSA-N (2-aminoacetyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC(=O)CN VGMIHYGISGNHKU-UHFFFAOYSA-N 0.000 description 1
- IGMAHSCLECVIDN-INIZCTEOSA-N (2s)-2-(dodecanoylamino)-3-(1h-imidazol-5-yl)propanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 IGMAHSCLECVIDN-INIZCTEOSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- ARXWAVXZIMFYNC-KRWDZBQOSA-N (2s)-5-(diaminomethylideneamino)-2-[dodecanoyl(ethyl)amino]pentanoic acid Chemical compound CCCCCCCCCCCC(=O)N(CC)[C@H](C(O)=O)CCCN=C(N)N ARXWAVXZIMFYNC-KRWDZBQOSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- FUOSTELFLYZQCW-UHFFFAOYSA-N 1,2-oxazol-3-one Chemical class OC=1C=CON=1 FUOSTELFLYZQCW-UHFFFAOYSA-N 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- AKGWUHIOEVNNPC-LURJTMIESA-N Arg-OEt Chemical class CCOC(=O)[C@@H](N)CCCNC(N)=N AKGWUHIOEVNNPC-LURJTMIESA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- JWGGSJFIGIGFSQ-UHFFFAOYSA-N N-dodecanoylglycine Chemical compound CCCCCCCCCCCC(=O)NCC(O)=O JWGGSJFIGIGFSQ-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-M alaninate Chemical compound CC(N)C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-M 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- ACHWEOLUTJAHLV-ZETCQYMHSA-N ethyl (2s)-2-amino-3-(1h-imidazol-5-yl)propanoate Chemical compound CCOC(=O)[C@@H](N)CC1=CN=CN1 ACHWEOLUTJAHLV-ZETCQYMHSA-N 0.000 description 1
- CUBZMGWLVMQKNE-LMOVPXPDSA-N ethyl (2s)-5-(diaminomethylideneamino)-2-(dodecanoylamino)pentanoate;hydrochloride Chemical compound Cl.CCCCCCCCCCCC(=O)N[C@H](C(=O)OCC)CCCNC(N)=N CUBZMGWLVMQKNE-LMOVPXPDSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229940070808 lauroyl aspartate Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/762—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/771—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/83—Mixtures of non-ionic with anionic compounds
- C11D1/831—Mixtures of non-ionic with anionic compounds of sulfonates with ethers of polyoxyalkylenes without phosphates
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
- C11D3/2079—Monocarboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/30—Amines; Substituted amines ; Quaternized amines
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/33—Amino carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/382—Vegetable products, e.g. soya meal, wood flour, sawdust
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/50—Perfumes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/008—Polymeric surface-active agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/14—Sulfonic acids or sulfuric acid esters; Salts thereof derived from aliphatic hydrocarbons or mono-alcohols
- C11D1/143—Sulfonic acid esters
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/72—Ethers of polyoxyalkylene glycols
- C11D1/721—End blocked ethers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种氨基酸衍生物、制备方法,以及该衍生物作为微生物抑制剂,在食品、饲料、家居护理以及个人护理品中的应用。The invention relates to an amino acid derivative, a preparation method, and the application of the derivative as a microbial inhibitor in food, feed, home care and personal care products.
背景技术Background technique
防腐剂用于食品、饲料、化妆品以及家具护理品中,主要作用是抑制微生物的生长和繁殖,以延长产品的保存时间,抑制产品腐败变质。随着化妆品、食品等行业的迅速发展,选择安全、高效的防腐体系,是目前政策法规、消费者以及研究工作者非常关注的问题。Preservatives are used in food, feed, cosmetics and furniture care products. The main function is to inhibit the growth and reproduction of microorganisms, so as to prolong the storage time of products and inhibit product spoilage. With the rapid development of cosmetics, food and other industries, choosing a safe and efficient anti-corrosion system is a matter of great concern to current policies, regulations, consumers and researchers.
许多传统防腐剂都被证实具有一定的负面作用,如DMDMH会释放甲醛,卡松系列含氯对某些肤质有刺激作用,布罗波尔可能会生成致癌物亚硝胺,IPBC可能导致摄入碘,三氯新对环境有负面影响。而尼泊金酯类,其苯环可能会在脂肪组织中累积或在特定的测试系统中显示某种模拟女性激素雌激素的能力。Many traditional preservatives have been proven to have certain negative effects. For example, DMDMH will release formaldehyde, the chlorine in Casson series can stimulate certain skin types, Bropol may produce carcinogen nitrosamines, and IPBC may cause ingestion Adding iodine, triclosan has a negative impact on the environment. As for parabens, their benzene rings may accumulate in adipose tissue or show some ability to mimic the female hormone estrogen in certain test systems.
法规对于防腐剂的使用规范也越来越严格,异塞唑晽酮类、甲醛释放体、羟苯酯类防腐剂的使用日趋受到限制。越来越严格的化妆品法规、消费者的安全意识的提高以及对防腐剂理解的误区、安全等因素,这一系列的变化促使传统防腐剂的使用总量明显下滑,亟待新的防腐剂开发与应用。The regulations on the use of preservatives are becoming more and more strict, and the use of isoxazolones, formaldehyde releasers, and paraben preservatives is increasingly restricted. More and more stringent cosmetics regulations, the improvement of consumers' safety awareness, misunderstandings about preservatives, safety and other factors, these series of changes have led to a significant decline in the total use of traditional preservatives, and the development of new preservatives is urgently needed. application.
月桂酰精氨酸乙酯盐酸盐是一类安全性、效果非常好的防腐剂,被应用于存食品、化妆品的防腐;被粮农组织/世卫组织联合食品添加剂专家委员会(JECFA)批准使用;另外,月桂酰精氨酸乙酯盐酸盐还符合欧盟、澳大利亚、加拿大以及新西兰等国家和地区的相关法规。Lauroyl arginine ethyl ester hydrochloride is a kind of safe and effective preservative, which is used in the preservation of preserved food and cosmetics; it is approved by the FAO/WHO Joint Expert Committee on Food Additives (JECFA) ; In addition, lauroyl arginine ethyl ester hydrochloride also complies with the relevant regulations of the European Union, Australia, Canada and New Zealand and other countries and regions.
月桂酰精氨酸乙酯盐酸盐是一种白色粉末,不利于添加到配方中,熔点在50-58℃,加入配方中时,需要预先将固体加热融化或使用溶剂溶解后,再添加到配方体系中,使得其添加非常麻烦,另外,即使选用溶剂溶解,其溶解度也非常有限,如其甘油中仅最大溶解仅20%左右。Lauroyl arginine ethyl ester hydrochloride is a white powder, which is not conducive to adding to the formula. Its melting point is 50-58 °C. When adding to the formula, it is necessary to heat and melt the solid in advance or use a solvent to dissolve it, and then add it to the In the formula system, it is very troublesome to add it. In addition, even if it is dissolved in a solvent, its solubility is very limited. For example, the maximum solubility in glycerin is only about 20%.
本发明提供一种精氨酸乙酯衍生物,该类产品熔点低,常温为澄清透明的液体,可以非常方便地溶于甘油等常见溶剂,溶解度高达70%,可以非常方便的用于食品、药品以及化妆品。The invention provides an arginine ethyl ester derivative, which has a low melting point and is a clear and transparent liquid at room temperature, can be easily dissolved in common solvents such as glycerin, and has a solubility of up to 70%, and can be very conveniently used in food, Medicines and cosmetics.
发明内容Contents of the invention
本发明的目的是提供一种脂肪酰氨基酸酯和脂肪酰氨基酸所形成的盐,该类衍生物为液体形式,对微生物具有更好的抑制或者杀灭效果,可方便与广泛应用于食品、饮料、医药、家居护理以及个人护理等产品中。The purpose of the present invention is to provide a salt formed by fatty acylamino acid ester and fatty acylamino acid. This kind of derivative is in liquid form, has better inhibitory or killing effect on microorganisms, and can be conveniently and widely used in food and beverages. , medicine, home care and personal care products.
本发明所提供的脂肪酰氨基酸和脂肪酰氨基酸酯形成的盐,对常见的的微生物具有很好的抑制作用,可以替代传统的防腐剂。The salt formed by the fatty acylamino acid and the fatty acylamino acid ester provided by the invention has a good inhibitory effect on common microorganisms and can replace traditional preservatives.
本发明的化合物具有天然来源、高安全性、低刺激性,降低过敏及毒性风险,并且具有易降解、环境友好等优点。The compound of the present invention has the advantages of natural origin, high safety, low irritation, reduced risk of allergy and toxicity, easy degradation, environmental friendliness and the like.
本发明提供的技术方案:一种利用脂肪酰氨基酸酯和脂肪酰氨基酸成盐的方法,将脂肪酰氨基酸酯和脂肪酰氨基酸成盐后,抑菌效果显著增强。The technical solution provided by the invention: a method of using fatty acylamino acid ester and fatty acyl amino acid to form a salt, after the fatty acyl amino acid ester and fatty acyl amino acid are formed into a salt, the antibacterial effect is significantly enhanced.
本发明所述脂肪酰氨基酸酯和脂肪酰氨基酸所形成的盐,对微生物具有抑制或者杀灭作用的盐的方法,具体步骤为:The salt formed by the fatty acylamino acid ester and the fatty acylamino acid described in the present invention, the method of the salt having an inhibitory or killing effect on microorganisms, the specific steps are:
(1)溶解:将脂肪酰氨基酸酯溶于溶剂,加热到50-55℃溶解;(1) Dissolution: Dissolve fatty acylamino acid ester in solvent and heat to 50-55°C to dissolve;
(2)成盐:脂肪酰氨基酸加到步骤(1)所得的脂肪酰氨基酸酯溶液中,混合搅拌至澄清透明;(2) Salt formation: Add fatty acyl amino acid to the fatty acyl amino acid ester solution obtained in step (1), mix and stir until clear and transparent;
(3)将步骤(2)中复配形成的盐减压蒸馏,除去溶剂。(3) Distill the salt compounded in step (2) under reduced pressure to remove the solvent.
步骤(1)中脂肪酰氨基酸酯具有(a) ~ (d)的化学结构,可以为通式(a) ~ (d)中的一种或几种的组合:In the step (1), the fatty acylamino acid ester has the chemical structure (a) ~ (d), which can be one or a combination of several general formulas (a) ~ (d):
I. 精氨酸衍生物及其常见的盐,其结构通式如式(a):I. Arginine derivatives and common salts thereof, the general structure of which is as formula (a):
(a)(a)
其中,R1是甲基、乙基、丙基或丁基;R2是碳原子数为6-22的脂肪酰基;Wherein, R 1 is methyl, ethyl, propyl or butyl; R 2 is a fatty acyl group with 6-22 carbon atoms;
II. 鸟氨酸衍生物及其常见的盐,其结构通式如式(b):II. Ornithine derivatives and common salts thereof, the general structure of which is shown in formula (b):
(b)(b)
其中,R1是甲基、乙基、丙基或丁基;R2是碳原子数为6-22的脂肪酰基;Wherein, R 1 is methyl, ethyl, propyl or butyl; R 2 is a fatty acyl group with 6-22 carbon atoms;
III. 赖氨酸衍生物及其常见的盐,其结构通式如式(c):III. Lysine derivatives and common salts thereof, the general structural formula of which is formula (c):
(c)(c)
其中,R1是甲基、乙基、丙基或丁基;R2是碳原子数为6-22的脂肪酰基;Wherein, R 1 is methyl, ethyl, propyl or butyl; R 2 is a fatty acyl group with 6-22 carbon atoms;
IV. 组氨酸衍生物及其常见的盐,其结构通式如式(d):IV. Histidine derivatives and common salts thereof, the general structural formula of which is formula (d):
(d)(d)
其中,R1是甲基、乙基、丙基或丁基;R2是碳原子数为6-22的脂肪酰基。Wherein, R 1 is methyl, ethyl, propyl or butyl; R 2 is a fatty acyl group with 6-22 carbon atoms.
步骤(1)中的溶剂为水或者乙醇;The solvent in step (1) is water or ethanol;
步骤(2)中的脂肪酰氨基酸,可以为一种或多种物质的组合,由碳原子数为5-21的脂肪酸和氨基酸缩合而成,其中氨基酸选自丙氨酸、精氨酸、天冬氨酸、半胱氨酸、谷氨酰胺、谷氨酸、组氨酸、异亮氨酸、甘氨酸、天冬酰胺、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、脯氨酸、丝氨酸、苏氨酸、色氨酸、酪氨酸、缬氨酸。The fatty acylamino acid in step (2) can be a combination of one or more substances, formed by condensation of fatty acids and amino acids with 5-21 carbon atoms, wherein the amino acids are selected from alanine, arginine, Partic acid, cysteine, glutamine, glutamic acid, histidine, isoleucine, glycine, asparagine, leucine, lysine, methionine, phenylalanine, Proline, Serine, Threonine, Tryptophan, Tyrosine, Valine.
对本发明所述脂肪酰氨基酸酯和脂肪酰氨基酸所形成的盐的抑菌体系进行评估测试。The antibacterial system of the salt formed by the fatty acylamino acid ester and the fatty acylamino acid of the present invention is evaluated and tested.
①防腐挑战测试:将脂肪酰氨基酸酯和脂肪酰氨基酸复配形成的盐体系加入到护肤品配方中,通过欧盟标准BP2002 XVIC 防腐效果测试方法分别对加入不同盐的配方溶液进行防腐挑战测试。① Antiseptic challenge test: The salt system formed by compounding fatty acylamino acid ester and fatty acyl amino acid is added to the formula of skin care products, and the antiseptic challenge test is carried out on the formula solutions added with different salts according to the EU standard BP2002 XVIC antiseptic effect test method.
②最小抑菌浓度测试:针对脂肪酰氨基酸酯和脂肪酰氨基酸复配形成的盐体系及月桂酰精氨酸乙酯进行防腐效果测试。防腐效果测试菌种见表1:②Minimum inhibitory concentration test: The antiseptic effect test was carried out on the salt system formed by the compound of fatty acyl amino acid ester and fatty acyl amino acid and ethyl lauroyl arginate. Antiseptic effect test strains are shown in Table 1:
③斑贴试验:针对脂肪酰氨基酸酯和脂肪酰氨基酸复配形成的盐体系及月桂酰精氨酸乙酯进行皮肤过敏性测试。③ Patch test: Skin allergy test was carried out for the salt system formed by the compound of fatty acylamino acid ester and fatty acyl amino acid and ethyl lauroyl arginate.
本发明所述的复配形成的盐体系与一般的化妆品原料具有很好的配伍性,与表面活性剂、油脂、溶剂、抗氧化剂等其他组分的复配性很好,与化妆品原料混匀乳化后,能使膏、霜、乳等基质细腻均匀,长期存放不分层、不渗水,剂型稳定。The salt system formed by compounding in the present invention has good compatibility with general cosmetic raw materials, and has good compoundability with other components such as surfactants, oils, solvents, antioxidants, etc., and can be mixed evenly with cosmetic raw materials After emulsification, it can make ointment, cream, milk and other bases fine and uniform, without stratification and water seepage for long-term storage, and the dosage form is stable.
以下通过实施例的具体实施方式再对本发明的上述内容作进一步的详细说明,但不仅限于以下的实施例。本发明包含上述技术思想下,根据本领域普通技术知识和惯用手段做出的各种替换或变更,均应包括在本发明的范围内。The above content of the present invention will be further described in detail through the specific implementation of the examples below, but not limited to the following examples. The present invention includes the above technical ideas, and various replacements or changes made according to common technical knowledge and customary means in this field shall be included in the scope of the present invention.
具体实施方式detailed description
为了更好的理解发明的实质,下面通过实例来详细说明发明内容,但本发明内容并不局限于此。以下各实施例中所用的脂肪酰氨基酸、脂肪酰氨基酸酯均为自制。In order to better understand the essence of the invention, the content of the invention will be described in detail below through examples, but the content of the invention is not limited thereto. The fatty acylamino acids and fatty acylamino acid esters used in the following examples are all self-made.
实施例1Example 1
(1)称取月桂酰精氨酸乙酯76.9g(0.2mol),加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 76.9g (0.2mol) of ethyl lauroyl arginate, add 30mL of ethanol, and heat to dissolve in a water bath at 60°C;
(2)将0.1mol月桂酰谷氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol lauroyl glutamic acid into (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品月桂酰精氨酸乙酯月桂酰谷氨酸盐为黄色液体,凝固点14℃。(4) The obtained product, ethyl lauroyl arginate lauroyl glutamate, is a yellow liquid with a freezing point of 14°C.
实施例2Example 2
(1)称取0.1mol椰油酰赖氨酸丙酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1mol propyl cocoyl lysine, add 30mL ethanol, and heat to dissolve in a water bath at 60°C;
(2)将0.1mol月桂酰甘氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol lauroyl glycine to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品椰油酰赖氨酸丙酯月桂酰甘氨酸盐为黄色液体,凝固点为18℃。(4) The obtained product, cocoyl lysine propyl ester lauroyl glycinate, is a yellow liquid with a freezing point of 18°C.
实施例3Example 3
(1)称取0.1mol月桂酰鸟氨酸乙酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1mol of ethyl lauroyl ornithine, add 30mL of ethanol, and heat in a water bath at 60°C to dissolve;
(2)将0.1mol月桂酰肌氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol lauroyl sarcosine to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品月桂酰鸟氨酸乙酯月桂酰肌氨酸盐为黄色透明液体,熔点13℃。(4) The obtained product, ethyl lauroyl ornithine lauroyl sarcosinate, is a yellow transparent liquid with a melting point of 13°C.
实施例4Example 4
(1)称取0.2mol月桂酰组氨酸乙酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.2mol of ethyl lauroyl histidine, add 30mL of ethanol, and heat to dissolve in a water bath at 60°C;
(2)将0.1mol月桂酰天冬氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol of lauroyl aspartic acid into (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品月桂酰组氨酸乙酯月桂酰天冬氨酸盐为黄色液体,凝固点为10℃。(4) The obtained product lauroyl histidine ethyl ester lauroyl aspartate is a yellow liquid with a freezing point of 10°C.
实施例5Example 5
(1)称取0.1mol椰油酰精氨酸丁酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1mol butyl cocoyl arginate, add 30mL ethanol, and heat to dissolve in a 60°C water bath;
(2)将0.1mol棕榈酰脯氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol palmitoylproline to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品椰油酰精氨酸丁酯棕榈酰脯氨酸盐为无色液体,凝固点为11℃。(4) The obtained product, butyl cocoyl arginate palmitoyl proline salt, is a colorless liquid with a freezing point of 11°C.
实施例6Example 6
(1)称取0.1mol棕榈酰赖氨酸甲酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1mol of palmitoyl lysine methyl ester, add 30mL of ethanol, and heat to dissolve in a water bath at 60°C;
(2)将0.1mol辛基酰酪氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1 mol of octanoyl tyrosine to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品棕榈酰赖氨酸甲酯辛基酰酪氨酸盐为淡黄色液体,凝固点为16℃。(4) The obtained product, palmitoyl lysine methyl ester octyl tyrosinate, is a light yellow liquid with a freezing point of 16°C.
实施例7Example 7
(1)称取0.1mol十八烷基酰组氨酸丁酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1mol butyl stearyl histidine, add 30mL ethanol, and heat to dissolve in a water bath at 60°C;
(2)将0.1mol癸基酰丙氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol decyl alanine to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品十八烷基酰组氨酸丁酯癸基酰丙氨酸盐为无色透明液体,凝固点为15℃。(4) The obtained product octadecyl histidine butyl ester decyl alaninate is a colorless transparent liquid with a freezing point of 15°C.
实施例8Example 8
(1)称取0.1mol己基酰鸟氨酸丙酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1mol hexylornithine propyl ester, add 30mL ethanol, and heat to dissolve in a 60°C water bath;
(2)将0.1mol月桂酰缬氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol lauroyl valine to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品己基酰鸟氨酸丙酯月桂酰缬氨酸盐为无色透明液体,凝固点为18℃。(4) The obtained product, hexylornithine propyl ester lauroyl valine salt, is a colorless transparent liquid with a freezing point of 18°C.
实施例9Example 9
(1)称取0.1mol二十烷基酰精氨酸甲酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1mol of eicosyl arginine methyl ester, add 30mL of ethanol, and heat to dissolve in a water bath at 60°C;
(2)将0.1mol椰油酰亮氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol cocoyl leucine to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品二十烷基酰精氨酸甲酯椰油酰亮氨酸盐为黄色液体,凝固点为12℃。(4) The obtained product eicosyl arginine methyl ester cocoyl leucine salt is a yellow liquid with a freezing point of 12°C.
实施例10Example 10
(1)称取0.1mol十六烷基酰组氨酸乙酯,加入30mL乙醇,60℃水浴加热溶解;(1) Weigh 0.1 mol of ethyl hexadecanyl histidine, add 30 mL of ethanol, and heat in a water bath at 60°C to dissolve;
(2)将0.1mol二十二烷基酰丝氨酸加入(1)中,搅拌混合均匀,得到盐体系;(2) Add 0.1mol behenylserine to (1), stir and mix evenly to obtain a salt system;
(3)将(2)中得到的体系减压蒸馏,除去乙醇;(3) Distill the system obtained in (2) under reduced pressure to remove ethanol;
(4)所得产品十六烷基酰组氨酸乙酯二十二烷基酰丝氨酸盐为黄色澄清透明液体,凝固点12℃。(4) The obtained product hexadecyl histidine ethyl ester behenyl serinate is a yellow clear liquid with a freezing point of 12°C.
实施例1-10所对应的脂肪酰氨基酸酯、脂肪酰氨基酸及所得的盐体系样品代号见表2:The sample codes of fatty acylamino acid esters, fatty acylamino acids and the resulting salt systems corresponding to Examples 1-10 are shown in Table 2:
实施例11Example 11
将上述抑菌盐体系进行产品配方实验,配方见表3至表6。The above-mentioned bacteriostatic salt system was subjected to a product formulation experiment, and the formulations are shown in Table 3 to Table 6.
实施例12Example 12
针对实施例1-10的抑菌盐体系,做防腐挑战实验,进行筛选验证。经过7天的菌类培养和28天周期的抑菌考察,结果判定见表7至表10。细菌、霉菌、酵母菌抑制实验的测试结果单位均为CFU/ml。For the bacteriostatic salt system of Examples 1-10, an antiseptic challenge experiment was carried out for screening and verification. After 7 days of fungal culture and 28 days of antibacterial investigation, the results are judged in Table 7 to Table 10. The unit of the test results of the bacteria, mold and yeast inhibition experiments is CFU/ml.
抑菌实验表明,脂肪酰氨基酸酯与脂肪酰氨基酸复配形成的盐体系对细菌、霉菌、酵母菌的抑制作用比较显著。Antibacterial experiments show that the salt system formed by the compounding of fatty acylamino acid esters and fatty acylamino acids has a significant inhibitory effect on bacteria, molds, and yeasts.
实施例13Example 13
针对实施例1-10中的抑菌盐体系及月桂酰精氨酸乙酯(LAE)进行化妆品相关的微生物(大肠杆菌、金黄色葡萄球菌、绿脓杆菌、洋葱假单胞菌、白色念珠菌、黑曲霉、糠秕马拉色菌)的最小抑菌浓度(MIC)值测试(单位:ug/mL):Cosmetics-related microorganisms (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Pseudomonas cepacia, Candida albicans) were tested against the antibacterial salt system and lauroyl arginine ethyl ester (LAE) in Examples 1-10. , Aspergillus niger, Malassezia furfur) minimum inhibitory concentration (MIC) value test (unit: ug/mL):
与月桂酰精氨酸乙酯盐酸盐相比,各抑菌体系对不同微生物的MIC值都低,说明抑菌体系对微生物的抑制作用更加显著。Compared with ethyl lauroyl arginine hydrochloride, the MIC values of each antibacterial system against different microorganisms were all lower, indicating that the antibacterial system had a more significant inhibitory effect on microorganisms.
实施例14Example 14
针对实施例1-10所得盐体系样品进行斑贴试验,并与月桂酰精氨酸乙酯盐酸盐(LAE)做比较。斑贴试验结果见表12。A patch test was performed on the salt system samples obtained in Examples 1-10, and compared with lauroyl arginine ethyl ester hydrochloride (LAE). The patch test results are shown in Table 12.
斑贴试验表明,相比于月桂酰精氨酸乙酯盐酸盐,脂肪酰氨基酸酯类和脂肪酰氨基酸的盐体系刺激性更小。Patch tests showed that fatty acylamino acid esters and fatty acylamino acid salt systems were less irritating than ethyl lauroyl arginate hydrochloride.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611096104.2A CN106588701A (en) | 2016-12-02 | 2016-12-02 | Amino acid derivative and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611096104.2A CN106588701A (en) | 2016-12-02 | 2016-12-02 | Amino acid derivative and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106588701A true CN106588701A (en) | 2017-04-26 |
Family
ID=58596682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611096104.2A Pending CN106588701A (en) | 2016-12-02 | 2016-12-02 | Amino acid derivative and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106588701A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108815151A (en) * | 2017-11-03 | 2018-11-16 | 华东师范大学 | Purposes of the lauroyl arginine ethyl ester as feed addictive |
CN108992437A (en) * | 2017-11-03 | 2018-12-14 | 华东师范大学 | Purposes of the lauroyl arginine ethyl ester as antibacterial agent for animals |
CN109984953A (en) * | 2019-05-22 | 2019-07-09 | 宁波御坊堂生物科技有限公司 | A kind of protein peptides take a shower, clean skin gel and preparation method thereof |
CN111170883A (en) * | 2020-01-06 | 2020-05-19 | 岳阳科罗德联合化学工业有限公司 | Fatty acyl amino acid polyhydroxy ester compound and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10114618A (en) * | 1996-10-07 | 1998-05-06 | Noevir Co Ltd | Liquid cosmetic |
CN101415641A (en) * | 2006-03-30 | 2009-04-22 | 味之素株式会社 | Modified clay mineral |
US20090318557A1 (en) * | 2003-12-22 | 2009-12-24 | Stockel Richard F | Dermatological compositions |
CN102167766A (en) * | 2011-03-21 | 2011-08-31 | 北京化工大学 | Vinyl amino acid (ester) polymer and preparation method thereof |
US20120328544A1 (en) * | 2003-12-22 | 2012-12-27 | Nevada Naturals, Inc. | Dermatological Treatment Methods And Formulations |
CN103232398A (en) * | 2012-04-28 | 2013-08-07 | 天津滨江药物研发有限公司 | Rosuvastatin amino acid salt as well as preparation method and application thereof |
CN103479532A (en) * | 2012-06-12 | 2014-01-01 | 苏州元素集化学工业有限公司 | Surfactant composition and uses thereof |
CN103732225A (en) * | 2010-03-23 | 2014-04-16 | Gojo工业公司 | Antimicrobial compositions |
-
2016
- 2016-12-02 CN CN201611096104.2A patent/CN106588701A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10114618A (en) * | 1996-10-07 | 1998-05-06 | Noevir Co Ltd | Liquid cosmetic |
US20090318557A1 (en) * | 2003-12-22 | 2009-12-24 | Stockel Richard F | Dermatological compositions |
US20120328544A1 (en) * | 2003-12-22 | 2012-12-27 | Nevada Naturals, Inc. | Dermatological Treatment Methods And Formulations |
CN101415641A (en) * | 2006-03-30 | 2009-04-22 | 味之素株式会社 | Modified clay mineral |
CN103732225A (en) * | 2010-03-23 | 2014-04-16 | Gojo工业公司 | Antimicrobial compositions |
CN102167766A (en) * | 2011-03-21 | 2011-08-31 | 北京化工大学 | Vinyl amino acid (ester) polymer and preparation method thereof |
CN103232398A (en) * | 2012-04-28 | 2013-08-07 | 天津滨江药物研发有限公司 | Rosuvastatin amino acid salt as well as preparation method and application thereof |
CN103479532A (en) * | 2012-06-12 | 2014-01-01 | 苏州元素集化学工业有限公司 | Surfactant composition and uses thereof |
Non-Patent Citations (4)
Title |
---|
EMIL C. BURUIANA等: "New polyacrylates with stilbene and (S)-phenylalanine side chains for sensor applications. Synthesis and properties", 《JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A: CHEMISTRY 》 * |
GEORG ZUNDEL: "PROTON TRANSFER IN AND PROTON POLARIZABILITY OF HYDROGEN BONDS: IR AND THEORETICAL STUDIES REGARDING MECHANISMS IN BIOLOGICAL SYSTEMS", 《JOURNAL OF MOLECULAR STRUCTURE》 * |
HIDEHARU MORI等: "Double-Hydrophilic and Amphiphilic Block Copolymers Synthesized by RAFT Polymerization of Monomers Carrying Chiral", 《MACROMOL. CHEM. PHYS.》 * |
石莹莹: "N-酰基氨基酸表面活性剂的性能及应用研究进展", 《河南化工》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108815151A (en) * | 2017-11-03 | 2018-11-16 | 华东师范大学 | Purposes of the lauroyl arginine ethyl ester as feed addictive |
CN108992437A (en) * | 2017-11-03 | 2018-12-14 | 华东师范大学 | Purposes of the lauroyl arginine ethyl ester as antibacterial agent for animals |
CN108992437B (en) * | 2017-11-03 | 2021-10-12 | 华东师范大学 | Use of lauroyl arginine ethyl ester as veterinary antibacterial agent |
CN109984953A (en) * | 2019-05-22 | 2019-07-09 | 宁波御坊堂生物科技有限公司 | A kind of protein peptides take a shower, clean skin gel and preparation method thereof |
CN109984953B (en) * | 2019-05-22 | 2022-08-19 | 宁波御坊堂生物科技有限公司 | Protein peptide gel for bath and skin cleaning and preparation method thereof |
CN111170883A (en) * | 2020-01-06 | 2020-05-19 | 岳阳科罗德联合化学工业有限公司 | Fatty acyl amino acid polyhydroxy ester compound and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106588701A (en) | Amino acid derivative and preparation method and application thereof | |
US20130053422A1 (en) | Antimicrobial Compositions | |
CN107624758B (en) | Compound composition containing p-hydroxyacetophenone and preparation method and application thereof | |
CN110292045B (en) | Preparation method and application of antimicrobial composition containing epsilon-polylysine | |
JP5637987B2 (en) | Preservative composition | |
CN114401708B (en) | Topical compositions | |
JP2019510037A (en) | Antibacterial peptide stimulant cleaning composition | |
JP2019535766A (en) | Antibacterial peptide stimulant cleaning composition | |
CN110840767A (en) | Preservative composition and preparation method and application thereof | |
KR101699468B1 (en) | Preservative composition containing PEG-2 phenyl ether as an active ingredient | |
KR20160044071A (en) | Preservative composition containing methyl 3-acetyl-4-hydroxybenzoate as an active ingredient | |
CN110200899A (en) | A kind of preservative and its preparation method and application | |
JP4915713B2 (en) | Antibacterial composition | |
JP2008195917A (en) | Antimicrobial cleaning composition | |
TW201201857A (en) | Agent suppressing decrease in preservative ability in amino-acid containing composition | |
KR101585795B1 (en) | Preservative composition containing diethylene glycol monobenzyl ether as an active ingredient | |
CN117751948A (en) | Composite disinfectant and preparation method and application thereof | |
BR112020007102B1 (en) | LIQUID CONCENTRATE FOR PRESERVATION | |
JP4444073B2 (en) | Cosmetics | |
KR20160025950A (en) | Cosmetic composition for treating acne | |
WO2013063072A1 (en) | Method for the formulation of hand sanitizer | |
KR20190042164A (en) | Composition and method for non-atiseptic wet tissues containing the ingredient to inhibit microbial propagation | |
WO2021104643A1 (en) | Preservative composition | |
JP6769052B2 (en) | Taurine-containing composition | |
JP2006008610A (en) | Preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170426 |